Cardiology Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents
Commentary

A paradigm shift in HF management

William Abraham, MD

Cover Story

Antibiotics and cardiac risk: A look at recent data, a call for increased awareness

FDA advisory panel decisions

FDA advisory panel recommends approval of edoxaban for prevention of stroke, systemic embolism

FDA News

FDA approves contact force-sensing ablation catheter

Feature

Everest expedition provides clues about BP at high altitudes

In the Journals

Low-molecular-weight heparin more cost-effective than unfractionated heparin for VTE prevention

Consensus statement published on appropriate use of left ventriculography

Implementing AHA guidelines reduced non-ICU telemetry use, saved costs

Hand-held ultrasound more accurate than physical exam for diagnosing CV abnormalities

Inappropriate use of cardiac stress tests with imaging linked to excess costs, harm

Angina symptoms linked with elevated risk for CV events in patients with stable CAD

AHA/ASA: Diet, exercise, BP control key for primary prevention of stroke

Platelet activation linked to MI in patients with pneumonia

Amiodarone use increased stroke, systemic embolism risk in patients with AF

AF may double risk for silent cerebral infarction

Telemonitoring reduced readmissions, costs in patients with HF

PFO closure may be cost-effective in long term

Industry News

Study of EES in women, minority patients underway

Meeting News Coverage

ISAR-SAFE: Net clinical outcomes no different for 6-month, 12-month DAPT after PCI

ITALIC: Outcomes comparable for 6 vs. 24 months of DAPT after PCI

Peripheral paclitaxel-eluting stent showed superior patency, clinical benefit at 5 years

Novel oral anticoagulants vs. warfarin: The debate continues

ODYSSEY ALTERNATIVE: Alirocumab superior to ezetimibe for LDL lowering in statin-intolerant patients

New trials underway to explore impact of anti-inflammatory therapy on CV events

Losartan, atenolol demonstrate similar efficacy, safety in Marfan syndrome

MagnaSafe: MRI safe for patients with pacemakers, ICDs

INHERIT: Losartan did not improve left ventricular mass in patients with hypertrophic cardiomyopathy

Cholesterol efflux capacity inversely associated with CV events

DAPT: Longer-duration therapy decreased stent thrombosis and MACCE, increased bleeding

DCB shows promise in femoropopliteal arterial disease, diabetes

3-D nitinol stent maintained primary patency at 2 years

AMBITION: Combination therapy reduced risk for clinical failure in patients with PAH

CANOPY: Carotid artery stenting safe, effective in standard-risk patients in a real-world setting

IMPROVE-IT: Ezetimibe added to statin therapy improved CV outcomes

Despite perceived differences, international hypertension guidelines 'mostly similar'

Genetic predisposition to elevated LDL tied to aortic valve calcium, aortic stenosis

Trial Scorecards

Trial Scorecard: RECORD-AF

Trial Scorecard: AFFORD

Trial Scorecard: VELOCITY

Trial Scorecard: RAISE-ETP

Trial Scorecard: DURABILITY Iliac

Trial Scorecard: DKCRUSH-VI

Trial Scorecard: Mimics

Trial Scorecard: CANOPY